Risks of valproate treatment in elderly patients with hypoalbuminemia - the importance of therapeutic dose measurement and a case report from gerontopsychiatric practice

View at publisher Summarise with VIRAT
Authors: Kateřina Skopalová, Jan Lužný
Cited by: 0
References: 6

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

V souasn gerontopsychiatrick praxi je zvykem zjiovat hladiny celkovho valprotu prostednictvm terapeutickho men hladin (TDM), vznam m ovem t stanoven hladin albuminu a zejmna pak voln frakce valprotu u konkrtnho pacienta. Prv voln frakce valprotu (tedy na albumin nenavzan a biologicky aktivn st liva) podmiuje nejen jeho farmakodynamickou aktivitu, ale i nedouc inky i dokonce toxicitu valprotu. U pacient vyho vku bv velmi astm nlezem hypoalbuminemie, co vede i k naven voln (na albumin nenavzan) frakce valprotu i pi jeho celkov normln hodnot. Klinickm dsledkem tohoto jevu pak mohou bt nedouc inky valprotu nebo i klinick projevy toxicity valprotu.

Fields of Study & Subjects

Pharmacological Effects and Toxicity Studies Epilepsy research and treatment Antibiotics Pharmacokinetics and Efficacy

Publication details

Journal / source
Psychiatrie pro praxi
Volume
27
Issue
1
Pages
49–51
Publication date
23 March 2026
Language
CS